Clinical trials in ovarian carcinoma: requirements for standard approaches and regimens
Open Access
- 1 October 2005
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 16 (suppl_8) , viii13-viii19
- https://doi.org/10.1093/annonc/mdi962
Abstract
Gynecologic Cancer Intergroup (GCIG) and its member organizations: 1GOG (USA); 2NCIC-CTG (Canada); 3AGO-OVAR (Germany); 4ANZGOG (Australia–New Zealand); 5JGOG (Japan); 6GINECO (France); 7SGCTG (Scotland, UK); 8MRC/NCRI (UK); 9NSGO (Scandinavia); 10RTOG (USA); 11GEICO (Spain); 12EORTC (Europe)Keywords
This publication has 23 references indexed in Scilit:
- Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trialThe Lancet, 2002
- Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-AnalysisJournal of Clinical Oncology, 2002
- A Critique of Surgical Cytoreduction in Advanced Ovarian CancerGynecologic Oncology, 2000
- Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year ResultsJNCI Journal of the National Cancer Institute, 2000
- Phase III Randomized Study of Cisplatin Versus Paclitaxel Versus Cisplatin and Paclitaxel in Patients With Suboptimal Stage III or IV Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2000
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian CancerNew England Journal of Medicine, 1995
- The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1994
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group studyGynecologic Oncology, 1992
- The diagnosis of ovarian cancer by pathologists: How often do diagnoses by contributing pathologists agree with a panel of gynecologic pathologists?American Journal of Obstetrics and Gynecology, 1991